Ownership

Anula Jayasuriya - Insider Trading & Ownership

Entity: Individual
Location: 5150 El Camino Real, Suite #A 32, Los Altos, CA
Summary: The estimated net worth of Anula Jayasuriya is at least $10.9K dollars as of October 10, 2024. Anula Jayasuriya is the Director of Lineage Cell Therapeutics, Inc. and owns shares of Lineage Cell Therapeutics, Inc. (LCTX) stock worth about $10.9K.
All Insider Reports: All Insider Reports

Ownership of Anula Jayasuriya

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
LCTX	Lineage Cell Therapeutics, Inc.	Director	$10.9K			Jul 1, 2024
JAGX	Jaguar Health, Inc.	Director				Oct 8, 2024

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Anula Jayasuriya:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
JAGX	Jaguar Health, Inc.	Stock option (right to buy)	Award		$0	0.00	+21K	21K	10/8/2024	Direct
LCTX	Lineage Cell Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+75K	75K	7/1/2024	Direct
LCTX	Lineage Cell Therapeutics, Inc.	Common Shares, no par value	Purchase		$10.9K	1.09	+10K	10K	12/29/2023	Direct
JAGX	Jaguar Health, Inc.	Common Stock	Award	+3991.2%	$0	0.00	+68.6K	70.3K	8/14/2023	Direct
JAGX	Jaguar Health, Inc.	Common Stock	Award		$0	0.00	+1.72K	1.72K	7/1/2023	Direct
JAGX	Jaguar Health, Inc.	Restricted stock units	Award	-100%	$0	0.00^*	-1.72K	0	7/1/2023	Direct
LCTX	Lineage Cell Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+50K	50K	7/1/2023	Direct
JAGX	Jaguar Health, Inc.	Restricted stock units	Award	-50%	$0	0.00	-1.72K	1.72K	4/6/2023	Direct
LCTX	Lineage Cell Therapeutics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+50K	50K	7/1/2022	Direct
LCTX	Lineage Cell Therapeutics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+50K	50K	7/1/2021	Direct

Showing 1 to 10 of 10 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.